VIVUS is seeking better living through chemistry. The pharmaceutical maker has several products in development and one marketed product: MUSE, a minimally invasive therapy for the treatment of erectile dysfunction. The MUSE applicator dispenses a localized dose of the drug alprostadil (a synthetic version of a natural vasodilator). VIVUS sells MUSE through a direct sales force in the US and through a distribution agreement with Swedish firm Meda in Europe and Paladin Labs in Canada. Drug candidates in the company's pipeline include potential treatments for obesity, sleep apnea, diabetes, and erectile dysfunction. VIVUS owns its own manufacturing facility, where it produces MUSE.